Expansion

GSK Unveils Plan for One of Europe’s Largest Life Science Campuses in Stevenage

GSK

Collaboration

ViiV Healthcare and Halozyme Enter Global Collaboration for ENHANZE® Drug Delivery Technology to Enable Development of “Ultra Long-Acting” Medicines for HIV

GSK

COVID-19 Vaccine

Sanofi and GSK COVID-19 Vaccine Candidate Demonstrates Strong Immune Responses Across All Adult Age Groups in Phase 2 Trial

Sanofi

Clinical Trials

Lilly, Vir Biotechnology and GSK Announce Positive Topline Data From the Phase 2 Blaze-4 Trial Evaluating Bamlanivimab With Vir-7831 in Low-risk Adults With Covid-19

GSK

GSK to Support Manufacture of Novavax’ COVID-19 Vaccine

GSK

COVID-19 Vaccine

Sanofi and GSK to Support COVAX with 200 Million Doses of COVID-19 Vaccine

GSK

FDA Approval

FDA Approves GSK’s BLENREP for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

GSK in Oncology

COVID-19 Vaccine Funding

Sanofi and GSK Selected for Operation Warp Speed to Supply United States Government with 100 Million Doses of COVID-19 Vaccine

Sanofi

COVID-19 Vaccine Collaboration

GSK and Medicago Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Candidate Vaccine

GSK

HIV

ViiV Healthcare’s Injectable Formulation Dosed Every Two Months Shows Higher Efficacy than Daily Oral PrEP

GSK

FDA Approves GSK's Zejula

GSK

Sanofi and GSK to Join Forces in COVID-19 Vaccine Collaboration

Sanofi

GSK's Asthma Biologic Approved

GSK

M&A

Bora Pharmaceuticals to Acquire GSK Mississauga-based Facility

Bora Pharmaceuticals

Partnership

Immatics and GSK Partner to Develop Novel Adoptive Cell Therapies

Immatics

Vaccine

CEPI and GSK Collaborate to Develop a Vaccine for Coronavirus

GSK

Vaccine

GSK Candidate Vaccine Demonstrates Sustained Level of Protection Against Active Pulmonary Tuberculosis

GSK

Divest

GSK Agrees to Divest Rabies and Tick-Borne Encephalitis Vaccines to Bavarian Nordic

GSK